
Anita M King
Examiner (ID: 15142)
Most Active Art Unit | 3632 |
Art Unit(s) | 3505, 2899, 3632 |
Total Applications | 2681 |
Issued Applications | 2122 |
Pending Applications | 127 |
Abandoned Applications | 408 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8796934
[patent_doc_number] => 08435801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Methods and compositions for the production of monoclonal antibodies'
[patent_app_type] => utility
[patent_app_number] => 13/090751
[patent_app_country] => US
[patent_app_date] => 2011-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16142
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13090751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/090751 | Methods and compositions for the production of monoclonal antibodies | Apr 19, 2011 | Issued |
Array
(
[id] => 7484359
[patent_doc_number] => 20110250173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'Methods and compositions for inhibition of Treg cells'
[patent_app_type] => utility
[patent_app_number] => 13/084900
[patent_app_country] => US
[patent_app_date] => 2011-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9123
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20110250173.pdf
[firstpage_image] =>[orig_patent_app_number] => 13084900
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/084900 | Methods and compositions for inhibition of Treg cells | Apr 11, 2011 | Abandoned |
Array
(
[id] => 8637621
[patent_doc_number] => 20130029424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'METHOD FOR THE GENERATION OF MONOCLONAL ANTIBODIES DERIVED FROM HUMAN B CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/640190
[patent_app_country] => US
[patent_app_date] => 2011-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 6303
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640190
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/640190 | METHOD FOR THE GENERATION OF MONOCLONAL ANTIBODIES DERIVED FROM HUMAN B CELLS | Apr 10, 2011 | Abandoned |
Array
(
[id] => 8066369
[patent_doc_number] => 20110243841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells'
[patent_app_type] => utility
[patent_app_number] => 13/074351
[patent_app_country] => US
[patent_app_date] => 2011-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 38074
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20110243841.pdf
[firstpage_image] =>[orig_patent_app_number] => 13074351
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/074351 | Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells | Mar 28, 2011 | Abandoned |
Array
(
[id] => 8779592
[patent_doc_number] => 20130101567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Methods to Expand a T Regulatory Cell Master Cell Bank'
[patent_app_type] => utility
[patent_app_number] => 13/639927
[patent_app_country] => US
[patent_app_date] => 2011-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 20860
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639927
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/639927 | Methods to Expand a T Regulatory Cell Master Cell Bank | Mar 27, 2011 | Abandoned |
Array
(
[id] => 8660521
[patent_doc_number] => 20130041349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'SUBSTITUTE THERAPY FOR GLUCOCORTICOIDS'
[patent_app_type] => utility
[patent_app_number] => 13/637195
[patent_app_country] => US
[patent_app_date] => 2011-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16409
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637195
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/637195 | SUBSTITUTE THERAPY FOR GLUCOCORTICOIDS | Mar 24, 2011 | Abandoned |
Array
(
[id] => 11678315
[patent_doc_number] => 09676832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Dendritic cell inhibitory proteins from ticks'
[patent_app_type] => utility
[patent_app_number] => 13/636469
[patent_app_country] => US
[patent_app_date] => 2011-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 21428
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636469
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/636469 | Dendritic cell inhibitory proteins from ticks | Mar 22, 2011 | Issued |
Array
(
[id] => 7697156
[patent_doc_number] => 20110229434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'USES OF MAMMALIAN CYTOKINE; RELATED REAGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/052404
[patent_app_country] => US
[patent_app_date] => 2011-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12834
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229434.pdf
[firstpage_image] =>[orig_patent_app_number] => 13052404
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/052404 | USES OF MAMMALIAN CYTOKINE; RELATED REAGENTS | Mar 20, 2011 | Abandoned |
Array
(
[id] => 8927583
[patent_doc_number] => 20130183343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'System and Method of Preparing and Storing Activated Mature Dendritic Cells'
[patent_app_type] => utility
[patent_app_number] => 13/635075
[patent_app_country] => US
[patent_app_date] => 2011-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17545
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13635075
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/635075 | System and Method of Preparing and Storing Activated Mature Dendritic Cells | Mar 14, 2011 | Abandoned |
Array
(
[id] => 8606124
[patent_doc_number] => 20130011436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'Methods and Compositions Containing Fc Fusion Proteins for Enhancing Immune Responses'
[patent_app_type] => utility
[patent_app_number] => 13/577990
[patent_app_country] => US
[patent_app_date] => 2011-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14162
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577990
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/577990 | Methods and compositions containing Fc fusion proteins for enhancing immune responses | Mar 10, 2011 | Issued |
Array
(
[id] => 8659482
[patent_doc_number] => 20130040311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERP29 AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/583312
[patent_app_country] => US
[patent_app_date] => 2011-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11671
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583312
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/583312 | Monoclonal antibody against necrosis marker ERP29 and use thereof | Mar 7, 2011 | Issued |
Array
(
[id] => 8950139
[patent_doc_number] => 20130195919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'INDUCED DENDRITIC CELL COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/582897
[patent_app_country] => US
[patent_app_date] => 2011-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 40520
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582897
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/582897 | INDUCED DENDRITIC CELL COMPOSITIONS AND USES THEREOF | Mar 6, 2011 | Abandoned |
Array
(
[id] => 7697104
[patent_doc_number] => 20110229486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'Monoclonal Antibodies Against NKG2A'
[patent_app_type] => utility
[patent_app_number] => 13/036240
[patent_app_country] => US
[patent_app_date] => 2011-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 36899
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229486.pdf
[firstpage_image] =>[orig_patent_app_number] => 13036240
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/036240 | Monoclonal Antibodies Against NKG2A | Feb 27, 2011 | Abandoned |
Array
(
[id] => 8696948
[patent_doc_number] => 20130058957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'DENDRITIC CELL IMMUNORECEPTOR AGONIST'
[patent_app_type] => utility
[patent_app_number] => 13/580689
[patent_app_country] => US
[patent_app_date] => 2011-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11542
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13580689
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/580689 | DENDRITIC CELL IMMUNORECEPTOR AGONIST | Feb 22, 2011 | Abandoned |
Array
(
[id] => 9989120
[patent_doc_number] => 09034317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-19
[patent_title] => 'Composition for inhibiting tumor cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 13/522741
[patent_app_country] => US
[patent_app_date] => 2011-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 25
[patent_no_of_words] => 9456
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522741
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/522741 | Composition for inhibiting tumor cell proliferation | Feb 9, 2011 | Issued |
Array
(
[id] => 6212384
[patent_doc_number] => 20110135684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro'
[patent_app_type] => utility
[patent_app_number] => 12/929701
[patent_app_country] => US
[patent_app_date] => 2011-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8615
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20110135684.pdf
[firstpage_image] =>[orig_patent_app_number] => 12929701
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/929701 | Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro | Feb 8, 2011 | Abandoned |
Array
(
[id] => 14731461
[patent_doc_number] => 10385120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination
[patent_app_type] => utility
[patent_app_number] => 13/576083
[patent_app_country] => US
[patent_app_date] => 2011-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19965
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13576083
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/576083 | Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination | Jan 31, 2011 | Issued |
Array
(
[id] => 6110339
[patent_doc_number] => 20110189200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'METHODS OF TREATING AUTOIMMUNE DISEASES WITH DLL4 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/015637
[patent_app_country] => US
[patent_app_date] => 2011-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 14077
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189200.pdf
[firstpage_image] =>[orig_patent_app_number] => 13015637
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/015637 | Methods of treating autoimmune diseases with Dll4 antagonists | Jan 27, 2011 | Issued |
Array
(
[id] => 8684358
[patent_doc_number] => 20130052642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'METHOD FOR THE IDENTIFICATION AND PURIFICATION OF HUMAN NATURALLY OCCURRING REGULATORY T CELLS (NTREGS)'
[patent_app_type] => utility
[patent_app_number] => 13/575247
[patent_app_country] => US
[patent_app_date] => 2011-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19420
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575247
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575247 | METHOD FOR THE IDENTIFICATION AND PURIFICATION OF HUMAN NATURALLY OCCURRING REGULATORY T CELLS (NTREGS) | Jan 23, 2011 | Abandoned |
Array
(
[id] => 7733323
[patent_doc_number] => 20120015890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'Use of Soluble Forms of CD83 and Nucleic Acids Encoding them for the Treatment or Prevention of Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/011380
[patent_app_country] => US
[patent_app_date] => 2011-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15404
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015890.pdf
[firstpage_image] =>[orig_patent_app_number] => 13011380
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/011380 | Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases | Jan 20, 2011 | Issued |